Font Size:

Case Counts

The Infectious Diseases & Outbreaks Division monitors the incidence and prevalence of communicable, zoonotic, and environmentally-related human diseases. This table summarizes cases reported over the last five years, as well as the cases reported year-to-date this year and last year.

 

Cases Reported Year-to-Date*

Totals by Year Reported

Condition

2025

2024

% Change

2024

2023

2022

2021

2020

Acute Flaccid Myelitis

0 0 -- 0 0 1 1 0^

Anthrax

0 0 -- 0^ 0 0 0 0

Arboviral Diseases (excludes Chikungunya virus, Dengue, and Zika virus)

1 0 100.0% 36 32 5 12 10

Babesiosis

0 2 -100.0% 4^ 1 0 1 1

Botulism

0 0 -- 1 2 2 0 1

Brucellosis

0 0 -- 0^ 0 0 1 1

Campylobacteriosis

558 511 9.2% 1153 878 813 745 665

Chikungunya virus - travel related, acquired out of state

0 0 -- 0 1 0 0 0

Cholera

0 0 -- 0 0 0 0 0

Coccidioidomycosis

4 5 -20.0% 10 12 12 13 5

Cryptosporidiosis

66 80 -17.5% 248 213 158 125 138

Cyclosporiasis

2 1 100.0% 30 140 19 6 9

Dengue - travel related, acquired out of state

1 3 -66.7% 11 5 5 1 0

E. coli, shiga toxin-producing (includes O157: H7)

76 81 -6.2% 163 170 159 138 100

Ehrlichiosis/Anaplasmosis

7 6 16.7% 13 5 10 24 12

Hansen's Disease (Leprosy)

1 0 100.0% 0 2 0 0 1

Hemolytic uremic syndrome (HUS)

3 0 300.0% 1 6 10 3 3

Influenza-associated pediatric mortality

2 1 100.0% 1 1 3 0 1

Legionellosis

41 36 13.9% 81 66 65 89 61

Listeriosis

7 4 75.0% 8 16 12 12 14

Lyme disease

11 18 -38.9% 38 34 32 51 15

Malaria - travel related, acquired out of state

0 2 -200.0% 9 11 8 8 2

Novel Influenza A virus infection

0 0 -- 0^ 0 0 0 0

Paratyphoid Fever

1 1 00.0% 7 0 2 2 1

Plague

0 0 -- 0 0 0 0 0^

Primary Amebic Meningoencephalitis (Naegleria fowleri)

0

0

--

0^

0

0

0

0

Q fever

0 0 -- 1 2 3 2 0

Rabies, animal

15 13 15.4% 28 38^ 45 44 51

Rabies, human

0 0 -- 0 0 0 0 0

Salmonellosis

363 351 3.4% 1093 879 996 861 891

Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)

0 0 -- 0 0 0 0 0

Shigellosis

62 65 -4.6% 125 100 81 88 346

Smallpox

0 0 -- 0 0 0 0 0

Spotted Fever Rickettsiosis

35 31 12.9% 72 81 118 121 90

Trichinellosis (Trichinosis)

0 0 -- 0 0 1 0 0

Tularemia

0 0 -- 1 1 3 0 1

Typhoid fever

0 0 -- 1 2 0 3 1

Vibriosis (non-Cholera)

18 19 -5.3% 54 37 41 34 26

Viral hemorrhagic fever

0 0 -- 0^ 0 0 0 0

VISA (Staphylococcus aureus, vancomycin-intermediate)

1 0 100.0% 1 1 1 1 0

VRSA (Staphylococcus aureus, vancomycin-resistant)

3 1 200.0% 1 0 0 1 1

Yellow Fever

0 0 -- 0 0 0 0 0

Zika virus - travel related, acquired out of state

0 0 -- 0 0 0 0 0

Other Investigations

1 2 -50% 2 5 0 1 0

Total

1279 1234 3.6% 3193 2741 2604 2389 2447

NOTE: Counts include finalized investigations among Alabama residents as of July 1, 2025. The Other investigations category includes a variety of conditions or events that have been investigated, but are not reportable in Alabama or do not fall into any other category (e.g., Histoplasmosis, Streptococcal toxic-shock syndrome, Yersiniosis, etc.). To see case counts for conditions investigated by other divisions, please see the following websites: Tuberculosis, Immunizations, Sexually Transmitted Diseases, and HIV/AIDS.

*Through MMWR Week 26 (week ending June 28, 2025), as compared to the same time period in the previous calendar year.

^The case definition was updated this year for this condition.





Page last updated: July 2, 2025